CSG’s Weapons Debut and Index Promotion Fail to Shield Stock From 62% Plunge
Published on 06/23/2026 at 13:57 | Redaktion boerse-global.de
The Czechoslovak Group (CSG) is suffering one of the most striking disconnects in European defence stocks right now. While the company deepens its product pipeline, enters new indices and boasts a record order book, its share price continues to slide. On Tuesday, the stock traded at €13.78, just a whisker above its 52-week low, after losing another 1.5% on the day.
The rout has been brutal since the January all-time high, with the stock shedding nearly 62% of its value. Even the RSI, at 32.5, signals deeply oversold territory. Yet the company’s operational momentum tells an altogether different story.
At the Eurosatory defence exhibition in Paris, CSG unveiled a flurry of new systems. The Tadeas 4x4 armoured vehicle made its world premiere in a command variant, featuring a welded hull and high ballistic protection. A separate agreement with Ukrainian Armor will develop advanced propulsion systems for Ukrainian missiles and drones, with plans for a joint venture and local production in Ukraine.
Further east, CSG is pushing ahead with the Danube Defence Systems joint venture in Tren?Ăn, Slovakia, alongside Turkish partner FNSS. CSG will hold a 51% stake. The centrepiece of that cooperation is the CFL-120 Karpat medium tank, which pairs main battle tank firepower with high mobility. A new air defence system called Trident, designed to counter drones, helicopters and rockets at multiple ranges, rounds out the offering. Longer-term, CSG is developing the Meander special vehicle with New Space Technologies; the first prototype is due in October 2026.
Should investors sell immediately? Or is it worth buying CSG?
To add to the contrast, CSG was also admitted this week to the STOXX Europe 600 Optimised Cyclicals index and the Industrial Goods & Services sub-index. The promotion should boost visibility among institutional investors. Yet the market has barely acknowledged the move. The stock closed Monday at €14.01, marking a 25% decline over the past 30 days. The distance from the €25 IPO price in January – and from the subsequent record high – now exceeds 60%.
None of the strategic announcements have been backed up by hard financial commitments. Investors are waiting for signed contracts and solid revenue forecasts. "The numerous partnerships must now convert into binding orders," one analyst noted. Until then, the selling pressure is unlikely to ease.
Operationally, CSG is firing on all cylinders. First-quarter revenue rose 14% to €1.54 billion, while operating profit reached €372 million. The order backlog swelled to €17 billion by the end of March. Management reaffirmed its full-year outlook of up to €7.6 billion in sales. The stock, meanwhile, trades well below its 50-day moving average of €17.41, a classic bearish signal.
CSG at a turning point? This analysis reveals what investors need to know now.
The next major catalyst comes on 7 August, when CSG reports first-half results. Strong figures could at least slow the descent, but for now the gap between the company’s expanding product portfolio and the market’s confidence remains wide.
Ad
CSG Stock: New Analysis - 23 June
Fresh CSG information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
